Sarah Cannon Research Institute shared a post on LinkedIn:
“At SCRI, we’re dedicated to advancing cancer research for patients. Our team is focused on accelerating progress through innovative clinical trials—because today’s research leads to tomorrow’s therapies.
Meet us at the 2025 ASCO Annual Meeting and discover the latest breakthroughs in oncology research.
Visit.”
More posts featuring ASCO25.